Discovery of Novel Pneumococcal Surface Antigen A (PsaA) Inhibitors Using a Fragment-based Drug Design Approach
- Megha Bajaj
- ,
- Sreeman K. Mamidyala
- ,
- Johannes Zuegg
- ,
- Stephanie L. Begg
- ,
- Miranda P. Ween
- ,
- Zhenyao Luo
- ,
- Johnny X. Huang
- ,
- Alastair G. McEwan
- ,
- Bostjan Kobe
- ,
- James C. Paton
- ,
- Christopher A. McDevitt
- , and
- Matthew A. Cooper
Abstract
Streptococcus pneumoniae is a leading cause of life-threatening bacterial infections, especially in young children in developing countries. Pneumococcal infections can be treated with β-lactam antibiotics, but rapid emergence of multidrug-resistant strains of S. pneumoniae over the past two decades has emphasized the need to identify novel drug targets. Pneumococcal surface antigen A (PsaA) is one such target, found on the cell surface of S. pneumoniae. It functions as a high-affinity substrate-binding protein, facilitating acquisition of Mn2+, which has an important role in protecting S. pneumoniae from reactive oxygen species and, hence, oxidative stress. Consequently, PsaA is essential for bacterial survival and an important virulence factor, which makes it a promising target for antibiotic drug development. To design novel PsaA inhibitors, we used a combination of de novo fragment-based drug discovery and in silico virtual screening methods. We profiled a collection of low molecular weight compounds that were selected based on their structural diversity and ability to bind to apo-PsaA in a virtual docking experiment. The screening resulted in two initial hits that were further optimized by structural variation to improve their potency while maintaining their ligand efficiency and favorable physicochemical properties. The optimized hits were validated using a cell-based assay and molecular dynamics simulations. We found that virtual screening substantially augmented fragment-based drug design approaches, leading to the identification of novel pneumococcal PsaA inhibitors.
Cited By
This article is cited by 15 publications.
- Rachel Berndsen, Taylor Cunningham, Lauren Kaelin, Makayla Callender, W. Dexter Boldog, Brianna Viering, Ashley King, Najwa Labban, Julie A. Pollock, Heather B. Miller, Meghan S. Blackledge. Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA. ACS Medicinal Chemistry Letters 2022, 13 (3) , 483-491. https://doi.org/10.1021/acsmedchemlett.1c00680
- Tanya Puccio, Karina S. Kunka, Seon‐Sook An, Todd Kitten. Contribution of a ZIP‐family protein to manganese uptake and infective endocarditis virulence in Streptococcus sanguinis. Molecular Microbiology 2022, 117 (2) , 353-374. https://doi.org/10.1111/mmi.14853
- P.S. Lannes‐Costa, J.S.S. Oliveira, G. Silva Santos, P.E. Nagao. A current review of pathogenicity determinants of Streptococcus sp.. Journal of Applied Microbiology 2021, 131 (4) , 1600-1620. https://doi.org/10.1111/jam.15090
- Ann-Kathrin Mix, Griseldis Goob, Erik Sontowski, Christof R. Hauck. Microscale communication between bacterial pathogens and the host epithelium. Genes & Immunity 2021, 6 https://doi.org/10.1038/s41435-021-00149-1
- F Cools, P Delputte, P Cos. The search for novel treatment strategies for Streptococcus pneumoniae infections. FEMS Microbiology Reviews 2021, 70 https://doi.org/10.1093/femsre/fuaa072
- Jie Huang, Mitchell Ringuet, Andrew E Whitten, Sofia Caria, Yee Wa Lim, Rahul Badhan, Victor Anggono, Mihwa Lee. Structural basis of the zinc-induced cytoplasmic aggregation of the RNA-binding protein SFPQ. Nucleic Acids Research 2020, 48 (6) , 3356-3365. https://doi.org/10.1093/nar/gkaa076
- Lucille F. van Beek, Kristin Surmann, H. Bart van den Berg van Saparoea, Diane Houben, Wouter S. P. Jong, Christian Hentschker, Thomas H. A. Ederveen, Elena Mitsi, Daniela M. Ferreira, Fred van Opzeeland, Christa E. van der Gaast – de Jongh, Irma Joosten, Uwe Völker, Frank Schmidt, Joen Luirink, Dimitri A. Diavatopoulos, Marien I. de Jonge. Exploring metal availability in the natural niche of Streptococcus pneumoniae to discover potential vaccine antigens. Virulence 2020, 11 (1) , 1310-1328. https://doi.org/10.1080/21505594.2020.1825908
- Kun Cao, Fubin Lai, Xin-Lu Zhao, Qiu-Xia Wei, Xin-Yu Miao, Ruiguang Ge, Qing-Yu He, Xuesong Sun. The mechanism of iron-compensation for manganese deficiency of Streptococcus pneumoniae. Journal of Proteomics 2018, 184 , 62-70. https://doi.org/10.1016/j.jprot.2018.06.004
- Jeffrey N. Weiser, Daniela M. Ferreira, James C. Paton. Streptococcus pneumoniae: transmission, colonization and invasion. Nature Reviews Microbiology 2018, 16 (6) , 355-367. https://doi.org/10.1038/s41579-018-0001-8
- Hehong Lv, Ziqi Ren, Heng Liu, Ganbing Zhang, Hanping He, Xiuhua Zhang, Shengfu Wang. The turn-off fluorescent sensors based on thioether-linked bisbenzamide for Fe 3+ and Hg 2+. Tetrahedron 2018, 74 (14) , 1668-1680. https://doi.org/10.1016/j.tet.2018.02.031
- Seema Patel, Nithya Mathivanan, Arun Goyal. Bacterial adhesins, the pathogenic weapons to trick host defense arsenal. Biomedicine & Pharmacotherapy 2017, 93 , 763-771. https://doi.org/10.1016/j.biopha.2017.06.102
- Hyung Jun Kim, Namyoul Kim, David Shum, Srigouri Huddar, Chul Min Park, Soojin Jang. Identification of Antipneumococcal Molecules Effective Against Different Streptococcus pneumoniae Serotypes Using a Resazurin-Based High-Throughput Screen. ASSAY and Drug Development Technologies 2017, 15 (5) , 198-209. https://doi.org/10.1089/adt.2017.789
- Anna Mullen, Jenny Hall, Janika Diegel, Isa Hassan, Adam Fey, Fraser MacMillan. Membrane transporters studied by EPR spectroscopy: structure determination and elucidation of functional dynamics. Biochemical Society Transactions 2016, 44 (3) , 905-915. https://doi.org/10.1042/BST20160024
- Cuong Thach Nguyen, Sang-Sang Park, Dong-Kwon Rhee. Stress responses in Streptococcus species and their effects on the host. Journal of Microbiology 2015, 53 (11) , 741-749. https://doi.org/10.1007/s12275-015-5432-6
- Chunquan Sheng, Guoqiang Dong, Chen Wang. Computational Fragment-Based Drug Design. 2015, 189-215. https://doi.org/10.1007/7653_2015_51